How have ACON shares performed in 2024?

Aclarion's stock was trading at $3.20 at the start of the year. Since then, ACON shares have decreased by 90.9% and is now trading at $0.29. View the best growth stocks for 2024 here .

Are investors shorting Aclarion?

Aclarion saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 62,000 shares, an increase of 9.3% from the March 15th total of 56,700 shares. Based on an average trading volume of 1,890,000 shares, the short-interest ratio is presently 0.0 days. Approximately 1.0% of the company's shares are sold short. View Aclarion's Short Interest .

When is Aclarion's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, July 1st 2024. View our ACON earnings forecast .

When did Aclarion's stock split?

Aclarion shares reverse split before market open on Thursday, January 4th 2024. The 1-16 reverse split was announced on Thursday, January 4th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, January 4th 2024. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

When did Aclarion IPO?

Aclarion (ACON) raised $12 million in an initial public offering on Friday, April 22nd 2022. The company issued 2,165,000 shares at a price of $4.50-$6.50 per share.

How do I buy shares of Aclarion?

Shares of ACON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:ACON

Aclarion (ACON) Stock Price, News & Analysis

→ Forget Nvidia, buy this A.I. Stock Now (From InvestorPlace) (Ad)

Free ACON Stock Alerts

$0.29

0.00 (0.00%)

(As of 04/17/2024 ET)

Compare

Today's Range: $0.28
▼
$0.30
50-Day Range: $0.29
▼
$1.92
52-Week Range: $0.27
▼
$37.92

Volume: 137,728 shs
Average Volume: 1.70 million shs
Market Capitalization: $2.07 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Aclarion alerts:

Ad InvestorPlace

Forget Nvidia, buy this A.I. Stock Now

Forget Nvidia, Microsoft or Google. Our tech expert and venture capitalist Luke Lango believes this is Elon Musk’s favorite A.I. stock. Why? Because this company is supplying Elon Musk with a key piece of advanced tech for his new A.I. venture.

Click here to see the details.

About Aclarion Stock (NASDAQ:ACON)

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

ACON Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ACON Stock News Headlines

April 16, 2024 | americanbankingnews.com

Aclarion, Inc. (NASDAQ:ACON) Sees Large Growth in Short Interest

April 2, 2024 | benzinga.com

Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

April 17, 2024 | InvestorPlace (Ad)

Forget Nvidia, buy this A.I. Stock Now

March 4, 2024 | finance.yahoo.com

Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs

February 27, 2024 | globenewswire.com

Aclarion Announces Closing of $3.0 Million Public Offering

February 26, 2024 | msn.com

Why Aclarion (ACON) Shares Are Down Over 60% Today

February 26, 2024 | globenewswire.com

Aclarion Announces Pricing of $3.0 Million Public Offering

February 26, 2024 | investorplace.com

Why Is Aclarion (ACON) Stock Down 19% Today?

April 17, 2024 | InvestorPlace (Ad)

Forget Nvidia, buy this A.I. Stock Now

February 26, 2024 | investorplace.com

Why Is Aclarion (ACON) Stock Down 19% Today?

February 1, 2024 | benzinga.com

Aclarion Stock (NASDAQ:ACON), Short Interest Report

January 30, 2024 | benzinga.com

Aclarion Stock (NASDAQ:ACON) Dividends: History, Yield and Dates

January 22, 2024 | markets.businessinsider.com

EQS-News: Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD

January 22, 2024 | markets.businessinsider.com

Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD

January 3, 2024 | ca.finance.yahoo.com

ACLARION INC. DL-,00001 (IT2.BE)

January 2, 2024 | finance.yahoo.com

Aclarion Announces Reverse Stock Split

November 27, 2023 | finance.yahoo.com

Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams

November 9, 2023 | finance.yahoo.com

Aclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan Adoption

November 6, 2023 | markets.businessinsider.com

Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD

October 25, 2023 | finance.yahoo.com

Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver

October 24, 2023 | finance.yahoo.com

Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting

October 2, 2023 | finance.yahoo.com

Aclarion Provides Updated Investor Presentation and Corporate Update

September 8, 2023 | barrons.com

Aclarion Inc.

August 25, 2023 | finance.yahoo.com

Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report

June 14, 2023 | finance.yahoo.com

Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI

June 8, 2023 | benzinga.com

Why Aclarion Stock Is Popping Today

June 8, 2023 | msn.com

ACON Skyrockets after Presentation of Nociscan Abstract

See More Headlines

Receive ACON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aclarion and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/17/2024
Next Earnings (Estimated): 7/01/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Medical laboratories
Sub-Industry: N/A
Current Symbol: NASDAQ:ACON
CUSIP: N/A
CIK: 1635077
Web: www.aclarion.com
Phone: 833-275-2266
Fax: N/A
Employees: 4
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-4,910,000.00
Net Margins: -6,480.47%
Pretax Margin: -6,512.92%
Return on Equity: -724.93%
Return on Assets: -249.67%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.40
Quick Ratio: 0.40

Sales & Book Value

Annual Sales: $80,000.00
Price / Sales: 26.54
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.38) per share
Price / Book: -0.78

Miscellaneous

Outstanding Shares: 7,150,000
Free Float: 5,559,000
Market Cap: $2.12 million
Optionable: Not Optionable
Beta: 0.44

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

Dr. Jeffrey John Thramann M.D. (Age 59)
Executive Chairman
Comp: $300k
Mr. John Lorbiecki (Age 60)
Chief Financial Officer
Comp: $225k
Mr. Ryan Bond (Age 51)
Chief Strategy Officer
Comp: $200k
Mr. Brent Ness (Age 57)
CEO, President & Director
Comp: $418.75k

Key Competitors

View All Competitors

ACON Stock Analysis - Frequently Asked Questions

How have ACON shares performed in 2024?: Aclarion's stock was trading at $3.20 at the start of the year. Since then, ACON shares have decreased by 90.9% and is now trading at $0.29.
View the best growth stocks for 2024 here.
Are investors shorting Aclarion?: Aclarion saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 62,000 shares, an increase of 9.3% from the March 15th total of 56,700 shares. Based on an average trading volume of 1,890,000 shares, the short-interest ratio is presently 0.0 days. Approximately 1.0% of the company's shares are sold short.
View Aclarion's Short Interest.
When is Aclarion's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, July 1st 2024.
View our ACON earnings forecast.
When did Aclarion's stock split?: Aclarion shares reverse split before market open on Thursday, January 4th 2024. The 1-16 reverse split was announced on Thursday, January 4th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, January 4th 2024. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

When did Aclarion IPO?: Aclarion (ACON) raised $12 million in an initial public offering on Friday, April 22nd 2022. The company issued 2,165,000 shares at a price of $4.50-$6.50 per share.
How do I buy shares of Aclarion?: Shares of ACON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ACON) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Aclarion (ACON) Stock Price, News & Analysis

About Aclarion Stock (NASDAQ:ACON)

ACON Stock Price History

ACON Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

ACON Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info